The SLC5A2 gene gives your kidneys instructions for taking glucose back from urine into the blood, so less sugar is lost each day. If it does not work properly, glucose can spill into the urine even when blood sugar is normal, which may cause frequent urination, thirst, or no symptoms at all. This gene can play a role in how your body responds to some diabetes medicines, which block this kidney pathway on purpose. Variants in the SLC5A2 gene are best known for a condition called familial renal glucosuria.
What is a gene?
Genes are sections of DNA that hold instructions your cells use to make molecules or regulate processes in the body. Some provide the directions for producing proteins, which are the parts of cells that do the work. Others mostly guide when certain processes happen, where they happen, and how active they are. In combination, genes affect how the body grows and works, and they can also shape your response to food, stress, or medications. For a deeper look at this topic, visit the LearnHub.
Overview
SLC5A2Gene function
What if the gene works
In the kidneys, the SLC5A2 gene helps move glucose from urine back into the blood. This lets your body keep most of its filtered sugar instead of losing it in urine.
Risk
What if the gene does not work
Variants in the SLC5A2 gene can reduce glucose reabsorption in the kidneys, causing renal glucosuria, with glucose leaking into urine. Milder variants may cause no symptoms, while more severe variants can lead to increased urination and thirst.
Treatment
What does that mean for your treatment
No SLC5A2-specific treatment or management approach is currently established for people with pathogenic variants in the SLC5A2 gene. The SLC5A2 gene is also the target of SGLT2 inhibitor drugs used for diabetes, chronic kidney disease, and heart failure, but that is separate from managing an inherited SLC5A2 variant.
Conditions associated with SLC5A2
Gene function
What if the gene works
Each day, your kidneys filter a large amount of sugar from the blood and then take almost all of it back. The SLC5A2 gene supports this routine step so useful fuel is not lost in urine. Understanding how the SLC5A2 gene helps the kidneys take glucose back into the body makes its day to day role easier to picture.
In the first part of the kidney's filtering tubes, this gene helps move glucose from the forming urine back into the body. This keeps a useful source of energy available for daily needs.
Its protein moves glucose together with sodium across kidney cell surfaces. This uses the body's normal salt difference to bring glucose in efficiently.
By reclaiming filtered glucose early in kidney processing, the SLC5A2 gene supports steady handling of sugar each day. This helps the body hold on to energy rather than wasting it.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and help create normal human diversity, such as differences in appearance, metabolism, or how the body responds to environmental influences. Many variants have no noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SLC5A2 gene can change the kidney glucose transporter so it folds poorly, does not reach the cell surface, or moves glucose less effectively. Milder variants may leave some transport activity, while more severe variants can cause little or no function, helping explain how SLC5A2 gene variants affect glucose reabsorption and why urinary glucose loss can vary.
How variants are linked to conditions
Pathogenic variants in the SLC5A2 gene cause familial renal glucosuria, a condition in which glucose passes into the urine even when blood sugar is normal. This is the main confirmed link between SLC5A2 gene variants and familial renal glucosuria in human genetics. Many people have no symptoms, while some may notice frequent urination, thirst, or occasional dehydration, and the condition is often found on urine testing.
A variant is not necessarily a diagnosis
Gene variants are a normal part of human biology and are common across the population. Most have no direct effect on health and simply reflect natural human diversity. For many genes, having a variant linked to a condition suggests a possible association rather than a confirmed diagnosis, especially when multiple genes and environmental factors are involved. In some cases, though, one well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For SLC5A2, the main factor is whether you inherited a gene change linked to familial renal glucosuria, a condition where sugar spills into the urine even when blood sugar is normal. There is not much broadly confirmed evidence that lifestyle or outside factors meaningfully change the chance of having this gene-related condition, although dehydration or pregnancy can make urine sugar loss more noticeable in some people.
Inheritance of SLC5A2 variants
SLC5A2-related familial renal glucosuria is usually inherited in an autosomal recessive pattern. This means a child typically inherits one SLC5A2 gene variant from each parent, and when both parents carry a variant, each pregnancy has a 25% chance of being affected, a 50% chance of producing a carrier, and a 25% chance of inheriting neither variant. In some families, carrying just one SLC5A2 gene variant can still lead to mild findings, so SLC5A2 gene variant inheritance may not look exactly the same in every relative.
What does my SLC5A2 result mean for my family?
SLC5A2 is most often linked to a kidney condition called familial renal glucosuria that usually runs in families in a recessive pattern. This means parents, brothers, sisters, and children may carry a changed SLC5A2 copy, even if they feel well. Full siblings may sometimes also have the condition, and children are more likely to be carriers unless the other parent also carries a change in SLC5A2.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for SLC5A2 variants usually uses a blood or saliva sample. A lab reads through the SLC5A2 gene, sometimes as part of a broader kidney panel, to look for variants. Results may show no relevant change, a benign variant, a likely relevant variant, or a variant of uncertain significance (a change whose meaning is still unclear).
When should I consider getting a genetic test?
Genetic testing for the SLC5A2 gene may be worth considering if urine tests repeatedly show sugar in the urine even though blood sugar is normal, especially when this seems to run in the family. It can help confirm an inherited cause of kidney sugar loss called familial renal glucosuria.
A genetic result is only one part of your health story
A genetic result can be informative, but how much it explains depends on the condition and the type of variant involved. Over time, factors such as age, environment, lifestyle, and medical history also shape how the body works. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. One person may break down a drug more slowly, while another may absorb less of it or be more sensitive to its effects. These common differences can influence how well a treatment works and how likely side effects are. This is one reason the same medication can feel helpful for one person but less effective or harder to tolerate for another.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences shape the way people respond to medications. It studies the relationship between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence how strongly a drug works or how the body processes it. This information can support treatment decisions that are more informed and more individualized. You can read more about this topic in LearnHub.
Drugs influenced by the SLC5A2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medicine choices, so questions about side effects, blood sugar treatment, or other health concerns are best discussed with your doctor. Researchers have studied whether changes in SLC5A2 affect how people respond to SGLT2 inhibitors, a group of diabetes medicines that help the body remove extra sugar through urine, but this is not a standard part of care.
History
The SLC5A2 gene entered medical research as scientists worked to understand why some families passed down a tendency to spill sugar into the urine despite otherwise normal health. Initially understood only through visible traits, later recognized as tied to a specific gene, this pattern helped connect older clinical observations with modern genetics. In the 1990s, researchers identified the SLC5A2 gene as the cause of inherited renal glucosuria, a condition in which the kidneys release glucose into urine more easily. From these first observations, research expanded steadily. That work later shaped the development of SGLT2 inhibitor medicines for type 2 diabetes, bringing the gene into a much wider clinical spotlight. Today, its history is closely linked to both rare inherited kidney findings and a major shift in diabetes treatment.